Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic

The aftermath of the initial phase of the COVID-19 pandemic may contribute to the widening of disparities in colorectal cancer (CRC) outcomes due to differential disruptions to CRC screening. This comparative microsimulation analysis uses two CISNET CRC models to simulate the impact of ongoing screening disruptions induced by the COVID-19 pandemic on long-term CRC outcomes. We evaluate three channels through which screening was disrupted: delays in screening, regimen switching, and screening discontinuation. The impact of these disruptions on long-term CRC outcomes was measured by the number of life-years lost due to CRC screening disruptions compared to a scenario without any disruptions. While short-term delays in screening of 3–18 months are predicted to result in minor life-years loss, discontinuing screening could result in much more significant reductions in the expected benefits of screening. These results demonstrate that unequal recovery of screening following the pandemic can widen disparities in CRC outcomes and emphasize the importance of ensuring equitable recovery to screening following the pandemic.

[1]  A. Jemal,et al.  Colorectal cancer statistics, 2023 , 2023, CA: a cancer journal for clinicians.

[2]  J. Peoples,et al.  Racial and ethnic disparities in who receives unemployment benefits during COVID-19 , 2022, SN Business & Economics.

[3]  J. London,et al.  Evolving Effect of the COVID-19 Pandemic on Cancer-Related Encounters , 2022, JCO clinical cancer informatics.

[4]  G. Wilensky The COVID-19 Pandemic and the US Health Care Workforce. , 2022, JAMA health forum.

[5]  B. Lebwohl,et al.  Impact of social determinants of health on colorectal cancer screening and surveillance in the COVID reopening phase , 2021, European journal of gastroenterology & hepatology.

[6]  C. Rutter,et al.  Too Good to Be True? Evaluation of Colonoscopy Sensitivity Assumptions Used in Policy Models. , 2021, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  A. Jemal,et al.  Unemployment and cancer screening: Baseline estimates to inform health care delivery in the context of COVID‐19 economic distress , 2021, Cancer.

[8]  R. Atun,et al.  Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis , 2021, The Lancet Oncology.

[9]  J. Haas,et al.  The trajectory of racial/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: A large U.S. academic center analysis , 2021, Preventive Medicine.

[10]  A. Jemal,et al.  Screening for Colorectal Cancer in the United States: Correlates and Time Trends by Type of Test , 2021, Cancer Epidemiology, Biomarkers & Prevention.

[11]  Jennifer S. Lin,et al.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2021, JAMA.

[12]  M. Cabana,et al.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[13]  Amy B. Knudsen,et al.  Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. , 2021, JAMA.

[14]  Jordan C Gemelas,et al.  Inequities in Employment by Race, Ethnicity, and Sector During COVID-19 , 2021, Journal of Racial and Ethnic Health Disparities.

[15]  M. Yaffe,et al.  The impact of episodic screening interruption: COVID-19 and population-based cancer screening in Canada , 2020, Journal of medical screening.

[16]  D. Lieberman,et al.  Screening and Surveillance Colonoscopy and COVID-19: Avoiding More Casualties , 2020, Gastroenterology.

[17]  L. Biancone,et al.  The impact of COVID-19 pandemic in the colorectal cancer prevention , 2020, International Journal of Colorectal Disease.

[18]  D. Rex,et al.  Proposal for the return to routine endoscopy during the COVID-19 pandemic , 2020, Gastrointestinal Endoscopy.

[19]  R. Trimble COVID-19 Dashboard , 2020 .

[20]  Jonathan Ozik,et al.  MICROSIMULATION MODEL CALIBRATION USING INCREMENTAL MIXTURE APPROXIMATE BAYESIAN COMPUTATION. , 2018, The annals of applied statistics.

[21]  Karen M Kuntz,et al.  Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. , 2016, JAMA.

[22]  S. Griffin,et al.  Distributional Cost-Effectiveness Analysis , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

[23]  J. Habbema,et al.  Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. , 2014, Annals of internal medicine.

[24]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[25]  J. GarcíaSánchez [Colonoscopic polypectomy and long-term prevention of colorectal cancer deaths]. , 2012 .

[26]  A. Zauber,et al.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. , 2012, The New England journal of medicine.

[27]  H. Brenner,et al.  Cost-effectiveness of Colorectal Cancer Screening , 2011, Epidemiologic reviews.

[28]  B. Larsen [Colorectal cancer screening]. , 2010, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[29]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[30]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[31]  Rob Boer,et al.  The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..